R. I. Lechler, M. Sykes, and A. W. Thomson, Organ transplantation-how much of the promise has been realized, Nat Med, vol.11, pp.605-613, 2005.

J. A. Bluestone, A. W. Thomson, and E. M. Shevach, What does the future hold for cell-based tolerogenic therapy?, Nat Rev Immunol, vol.7, pp.650-654, 2007.

E. K. Geissler, The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocytederived cells, Transplant Res, vol.1, p.11, 2012.

P. Riquelme, E. K. Geissler, and J. A. Hutchinson, Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs, Transplant Res, vol.1, p.17, 2012.

M. B. Lutz, R. M. Suri, and M. Niimi, Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo, Eur J Immunol, vol.30, pp.1813-1822, 2000.

M. C. Baas, C. Kuhn, and F. Valette, Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance, J Immunol, vol.193, pp.4696-4703, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02164449

J. Liao, X. Wang, and Y. Bi, Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide, J Leukoc Biol, vol.96, pp.675-684, 2014.

M. R. Garcia, L. Ledgerwood, and Y. Yang, Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice, J Clin Invest, vol.120, pp.2486-2496, 2010.

M. Hill, P. Thebault, and M. Segovia, Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferongamma and Epstein-Barr virus-induced gene 3, Am J Transplant, vol.11, pp.2036-2045, 2011.

M. Segovia, C. Louvet, and P. Charnet, Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen crosspresentation, Am J Transplant, vol.14, pp.1021-1031, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02167834

P. Riquelme, S. Tomiuk, and A. Kammler, IFN-gamma-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients, Mol Ther, vol.21, pp.409-422, 2013.

J. N. Stoop, J. H. Robinson, and C. M. Hilkens, Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?, Ann Rheum Dis, vol.70, pp.1526-1533, 2011.

M. Ioannou, T. Alissafi, and I. Lazaridis, Crucial role of granulocytic myeloidderived suppressor cells in the regulation of central nervous system autoimmune disease, J Immunol, vol.188, pp.1136-1146, 2012.

B. Ning, J. Wei, and A. Zhang, Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis, PLoS One, vol.10, p.131152, 2015.

B. Yin, G. Ma, and C. Y. Yen, Myeloid-derived suppressor cells prevent type 1 diabetes in murine models, J Immunol, vol.185, pp.5828-5834, 2010.

S. J. Divito, Z. Wang, and W. J. Shufesky, Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation, Blood, vol.116, pp.2694-2705, 2010.

K. R. Garrod, C. K. Chang, and F. C. Liu, Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival, J Immunol, vol.177, pp.863-868, 2006.

H. R. Turnquist, G. Raimondi, and A. F. Zahorchak, Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance, J Immunol, vol.178, pp.7018-7031, 2007.

P. M. Emmer, J. Van-der-vlag, and G. J. Adema, Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness, Transplantation, vol.81, pp.1451-1459, 2006.

A. Moreau, E. Varey, and G. Beriou, Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials, Front Immunol, vol.3, p.218, 2012.

A. E. Morelli and A. W. Thomson, Tolerogenic dendritic cells and the quest for transplant tolerance, Nat Rev Immunol, vol.7, pp.610-621, 2007.

D. I. Gabrilovich and S. Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, vol.9, pp.162-174, 2009.

E. Peranzoni, S. Zilio, and I. Marigo, Myeloid-derived suppressor cell heterogeneity and subset definition, Curr Opin Immunol, vol.22, pp.238-244, 2010.

S. Rossner, C. Voigtlander, and C. Wiethe, Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro, Eur J Immunol, vol.35, pp.3533-3544, 2005.

S. L. Highfill, P. C. Rodriguez, and Q. Zhou, Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, Blood, vol.116, pp.5738-5747, 2010.

E. Eruslanov, I. Daurkin, and J. Ortiz, Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells, J Leukoc Biol, vol.88, pp.839-848, 2010.

I. Marigo, E. Bosio, and S. Solito, Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor, Immunity, vol.32, pp.790-802, 2010.

L. Drujont, L. Carretero-iglesia, and L. Bouchet-delbos, Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection, PLoS One, vol.9, p.100013, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02164512

J. A. Hutchinson, P. Riquelme, and B. Sawitzki, Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients, J Immunol, vol.187, pp.2072-2078, 2011.

N. Giannoukakis, B. Phillips, and D. Finegold, Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients, Diabetes Care, vol.34, pp.2026-2032, 2011.

A. Moreau, E. Varey, and L. Bouchet-delbos, Cell therapy using tolerogenic dendritic cells in transplantation, Transplantation research, vol.1, p.13, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00796724

E. L. Gautier, T. Shay, and J. Miller, Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages, Nat Immunol, vol.13, pp.1118-1128, 2012.

M. M. Meredith, K. Liu, and G. Darrasse-jeze, Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage, J Exp Med, vol.209, pp.1153-1165, 2012.

J. C. Miller, B. D. Brown, and T. Shay, Deciphering the transcriptional network of the dendritic cell lineage, Nat Immunol, vol.13, pp.888-899, 2012.

M. Segovia, M. C. Cuturi, and M. Hill, Preparation of mouse bone marrowderived dendritic cells with immunoregulatory properties, Methods Mol Biol, vol.677, pp.161-168, 2011.

V. De-wilde, N. Van-rompaey, and M. Hill, Endotoxin-induced myeloidderived suppressor cells inhibit alloimmune responses via heme oxygenase-1, Am J Transplant, vol.9, pp.2034-2047, 2009.

L. Carretero-iglesia, M. Hill, and M. C. Cuturi, Generation and characterization of mouse regulatory macrophages, Methods Mol Biol, vol.1371, pp.89-100, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01498334

E. Segura and S. Amigorena, Inflammatory dendritic cells in mice and humans, Trends Immunol, vol.34, pp.440-445, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00846095

M. B. Lutz and G. Schuler, Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?, Trends Immunol, vol.23, pp.445-449, 2002.

C. Brinster and E. M. Shevach, Bone marrow-derived dendritic cells reverse the anergic state of CD4 + CD25+ T cells without reversing their suppressive function, J Immunol, vol.175, pp.7332-7340, 2005.

M. Hill, S. Tanguy-royer, and P. Royer, IDO expands human CD4 + CD25high regulatory T cells by promoting maturation of LPStreated dendritic cells, Eur J Immunol, vol.37, pp.3054-3062, 2007.

M. Menges, S. Rossner, and C. Voigtlander, Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigenspecific protection of mice from autoimmunity, J Exp Med, vol.195, pp.15-21, 2002.

K. Pletinckx, M. Vaeth, and T. Schneider, Immature dendritic cells convert anergic nonregulatory T cells into Foxp3-IL-10+ regulatory T cells by engaging CD28 and CTLA-4, Eur J Immunol, vol.45, pp.480-491, 2015.

S. Yamazaki, T. Iyoda, and K. Tarbell, Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells, J Exp Med, vol.198, pp.235-247, 2003.

S. Fujita, Y. Sato, and K. Sato, Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4 + CD25 + Foxp3+ regulatory T cells, Blood, vol.110, pp.3793-3803, 2007.

M. Li, X. Zhang, and X. Zheng, Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference, J Immunol, vol.178, pp.5480-5487, 2007.

K. Tomihara, M. Guo, and T. Shin, Antigen-specific immunity and crosspriming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells, J Immunol, vol.184, pp.6151-6160, 2010.

S. Nagaraj, J. I. Youn, and D. I. Gabrilovich, Reciprocal relationship between myeloid-derived suppressor cells and T cells, J Immunol, vol.191, pp.17-23, 2013.

H. S. Chou, C. C. Hsieh, and R. Charles, Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells, Transplantation, vol.93, pp.272-282, 2012.

P. Conde, M. Rodriguez, and W. Van-der-touw, DC-SIGN(+) macrophages control the induction of transplantation tolerance, Immunity, vol.42, pp.1143-1158, 2015.